If a group of experimental animals is exposed to a carcinogenic treatment, the actual number of (for example) hepatomata that will be discovered depends not only on the carcinogenic force of the treatment but also on the mortality that occurs among the animals from causes other than hepatomata. The connection between intercurrent death rates and the hepatoma crop is subtle, since (a) death causes necropsy of the dead animal to occur, and if an otherwise unsuspected hepatoma is discovered at necropsy, then the death of the animal caused the discovery of that hepatoma; (b) if an animal who would have developed a hepatoma at a certain time dies (of some other tumour, or of worms, perhaps) before that hepatoma is big enough to be found, then death has prevented the discovery of that hepatoma.
Animal experiinents reported in the British Journal of Cancer in which the numbers of tumours resulting from different carcinogenic regimens are compared must be described in such a way that estimates of the relative carcinogenic forces of the different regimens are not biased by heterogeneous mortality patterns in the different treatment groups. The following suggestions may prove helpful in achieving this. These suggested methods require only that a sharp distinction be made between " incidental " (discovered at the necropsy of an animal which died of something else) tumours and " non-incidental" (other) tumours.
A pos8ible method of dealing with difficulty (a):
Comparisons of crops of " incidental " tumours Divide the experimental lifetime of the animals up into periods (each perhaps of a few weeks' duration) which are short enough for it to be reasonable to compare all the necropsies that take place in one period with each other. Now produce a table of all the necropsies of animals which died from causes other than a hepatoma and in which no hepatoma had been found before their death (including animals which were deliberately sacrificed while still apparently healthy), giving the numbers of these necropsies at which hepatomata were discovered. Table II are derived from the observed numbers in Table I by using the fact that if A, B and C are equally hepatocarcinogenic then all such necropsies in any one period are equally likely to reveal hepatomata. Check the calculations for periods 2 and 6 if this is not clear.)
Comparison of the overall observed and the overall expected tumour crops, as in Table III , for the three different treatment groups is now valid no matter what differences between the necropsy rates in the three groups existed. As a formal statistical test of whether such extreme differences as those found in Table III could arise by chance alone if there was no difference between the hepatocarcinogenicity of treatments A, B and C, we examine the statistic (9 -8-48 )2+ (2 9-13)2+(20 -13.39)2 = 8-86 8.48
9113-39
The probability of getting differences between observed and expected numbers as extreme as those in Table III In this section tumours which are either detected during life or cause death are discussed. The method used is very similar to that used in the previous section, in that the period of the experiment is divided up into sub-periods and in that we compare the treatment groups with each other entirely within single sub-periods, but in, this case the appropriate sub-periods $ire much finer (generally of no more than one week) and the denominator is " all animals alive at the beginning of the sub-period ".
A table of overall observed and overall expected tumours is then abstracted, and statistical analysis is similar to that following Table III .
Again, a chi-squared test can be used which is similar to that described following (The data of Table IV may be displayed by means of a cumulative-incidence grap'i. The " incidence"
in Group C in Week 15 is 3/29 = 0-103 and in Week 16 it is 1/21 = 0-048. The cumulative incidence for Group C by the end of a particular week is the sum of all the separate weekly incidences in Group C up to and including that week. Graphs of the weekly cumulative incidences in the 3 treatment groups describe the cancer crops in those groups visually, and are not biased by mortality from other causes.) Table I  (although calculation of Tables IT and VI should be from the extended version of Table IV (This is also known as the actuarial method, and is equivalent to the cumulative-incidence method described below Table IV Tables I, II and III or  the statistical methods of Tables IV, V and VI should be used. All skin tumours, whether benign or malignant, and almost all mammary tumours, will be ' non-incidental ".
7. In Tables I-VII , treatments A, B and C could, of course, be different dose levels of the same substance. If this is so, the most sensitive test of whether the substance has any carcinogenic effect may be to pool all the groups except the highest dose group, and to compare two groups only: H, the highest dose group, with L, the pooled lower dose and control groups.
8. If the relationship between the ' nonincidental" cancer crops in the different treatment groups is governed by a Weibull distribution (which is often the case), then no other statistical method can be more sensitive for detecting small differences betwreen the carcinogenic forces ofdifferent treatments than the comparison of the observed and expected numbers of tumours in those groups.
REFERENCES TO THE STATISTICAL LITERATURE
The text so far has been self-contained and should enable experimentalists to perform valid statistical significance tests and, perhaps, to illustrate their results by cumulativeincidence graphs with little or no need for statistical advice. In most experiments, these few techniques will be sufficient to get everything possible out of the data. However, more complicated techniques may be needed for the analysis of large or complex experiments and statistical advice will then be required. The following five statistical references may be of use to statisticians who are thus consulted. Although their content is outside the scope of this paper (which, it is hoped, will be read by experimentalists as well as by statisticians), it often happens that experimentalists consult statisticians who have not previously analysed many carcinogenesis experiments. If this happens, it may be useful for the experimentalist to be able to direct the attention of the statistician to the following descriptions of the contents of these five references. It is perfectly possible to choose not to use any of them in detailed studies of carcinogenesis data, but it is probably unwise for statisticians to undertake such studies in ignorance of the contents of all of them.
(1) Statements such as 'P < 0*04" derived by taking a (2) The " life-table " (also called the actuarial ") method has sometimes been used as an alternative to the "cumulativeincidence " method described after 
